Reinilde Heyrman
Hoofd Techniek/Wetenschap/O&O bij MEDPACE HOLDINGS, INC.
Actieve functies van Reinilde Heyrman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MEDPACE HOLDINGS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2017 | - |
Loopbaan van Reinilde Heyrman
Eerdere bekende functies van Reinilde Heyrman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IKARIA, INC. | Corporate Officer/Principal | 01-01-2012 | - |
| BELLEROPHON THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2014 | - |
| Bedrijfssecretaris | 01-02-2014 | - |
Opleiding van Reinilde Heyrman
| University of Antwerp | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| België | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Secretary | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| MEDPACE HOLDINGS, INC. | Commercial Services |
| Bedrijven in privébezit | 1 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
- Beurs
- Insiders
- Reinilde Heyrman
- Ervaring
